RFK Jr. May Block Government Scientists From Publishing in Top Medical Journals

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 29, 2025.

By I. Edwards HealthDay Reporter

THURSDAY, May 29, 2025 — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government scientists to publish research in top medical journals.

Kennedy made the statement on a podcast called The Ultimate Human where he called the journals “corrupt” and said they were controlled by drug companies.

“We’re probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA and those other journals," Kennedy said.

All three journals are known for publishing peer-reviewed studies and are widely read by health professionals around the world.

JAMA and The Lancet each get more than 30 million visits to their websites every year. The New England Journal of Medicine reaches more than 1 million readers weekly, in print and online, The Washington Post reported.

None of the journals responded right away to Kennedy’s comments.

Kennedy said he wants HHS to create its own journals instead. They would “become the preeminent journals, because if you get [NIH] funding, it is anointing you as a good, legitimate scientist.”

But some public health experts strongly disagreed.

“Banning NIH-funded researchers from publishing in leading medical journals and requiring them to publish only in journals that carry the RFK Jr. seal of approval would delegitimize taxpayer-funded research," Dr. Adam Gaffney, an assistant professor at Harvard Medical School, told The Post.

Gaffney also warned that drug approvals rely on science. While saying it’s important to guard against commercial interests, he warned that Kennedy’s plans — along with funding cuts and anti-vaccine views — could hurt public health.

On the podcast, Kennedy also criticized government agencies under HHS, including the U.S. Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), National Institutes of Health (NIH), and Medicare and Medicaid offices. He described them as “sock puppets” for the pharmaceutical industry.

The podcast came out shortly after Kennedy announced his department would stop recommending the COVID-19 vaccine for healthy children and pregnant women, bypassing CDC guidance.

Last week, the administration also released a new “Make America Health Again (MAHA) report” that challenged common views in medicine, including on vaccines.

The Post said the report included misleading information and claims not backed by strong evidence.

In April, a U.S. attorney sent a rare letter to the journal Chest, questioning its editorial policies. Critics said the move threatened freedom of speech, The Post reported.

Meanwhile, NIH funding has dropped by more than $3 billion since January, and many top universities are losing out on funding for research.

Kennedy has also led a major staff reduction at HHS, with about 20,000 federal workers cut — affecting almost every part of the agency, The Post said.

The cuts and funding freezes have led some U.S. scientists to consider leaving the country for jobs elsewhere. Countries like France, Germany, Spain and China are now actively recruiting American researchers.

Sources

  • The Washington Post, May 28, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-05-30 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords